MICHAEL DUNKLE: Open Payments
NPI 1306389846 · GREENWOOD VILLAGE, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$461 in 22 payments from 15 companies in 2025. Trend: 2023 $132 · 2024 $794 · 2025 $461
Food & beverage: $461
| Company | Payments | Amount |
|---|---|---|
| Kite Pharma, Inc. | 3 | $73 |
| Incyte Corporation | 3 | $68 |
| Novartis Pharmaceuticals Corporation | 3 | $60 |
| SERVIER PHARMACEUTICALS LLC | 2 | $42 |
| ABBVIE INC. | 1 | $28 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $25 |
| Exelixis Inc. | 1 | $23 |
| GENZYME CORPORATION | 1 | $22 |
| Legend Biotech USA Inc. | 1 | $21 |
| JAZZ PHARMACEUTICALS INC. | 1 | $21 |
Products named: Yescarta, KISQALI, JAKAFI, IMBRUVICA, FRUZAQLA, CABOMETYX, Voranigo, SARCLISA.
Industry payments across CO — which companies pay providers there.
